Funding for this research was provided by:
University of Central Lancashire MedTech Solutions Group
Article History
Received: 25 July 2023
Accepted: 21 December 2023
First Online: 29 January 2024
Declarations
:
: Ethical approval was obtained through the UCLan Research Ethics Committee, approval #HEALTH0287—amended. Consent to participate is obtained by Care Response and includes the option of use for research by third parties.
: Consent is obtained in writing by Care Response for all participants and includes the option of use for research and publication by third parties.
: Jonathan Field is the CEO/Director of Clinical Transparency, Ltd., which owns Care Response. Kenneth Young and Helen Young declare that they have no conflict of interest.